Top Bulls Reasons To Buy — Vote below!

Add a New Bulls Reason

Company: Icad (ICAD)
Current price:
Headline: (100 character max)
Analysis:
Cancel
100%
agree
1 votes

  ICAD receives approval for Virtual Colonoscopy

50,000 people each year die from colon cancer. Statistics prove that early detection saves lives, yet 50% of people over 50 won't get the exam because it is painful, takes all day, and there are risks, such as perforation of the colon. ICAD's virtual colonoscopy eliminates all those reasons and is 90% effective. It was approved ny the FDA a few weeks ago, and has not relly hit the pipeline yet. Soon, hospitals across the nation will discover what Europe and Canada already know, This is easy and it saves lives!

(100 character max) Cancel
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki